CATX Annual CAPEX
N/A
01 December 2023
Summary:
CATX annual capital expenditures is not available.CATX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CATX Quarterly CAPEX
N/A
01 September 2024
Summary:
CATX quarterly capital expenditures is not available.CATX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CATX TTM CAPEX
N/A
01 September 2024
Summary:
CATX TTM capital expenditures is not available.CATX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CATX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CATX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Perspective Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $151.00 K(-43.2%) | - | - |
| Sept 2022 | - | $90.00 K(-14.3%) | $302.00 K(+13.5%) |
| June 2022 | - | $105.00 K(+303.8%) | $266.00 K(-3.6%) |
| June 2022 | $266.00 K(-30.2%) | - | - |
| Mar 2022 | - | $26.00 K(-67.9%) | $276.00 K(-19.5%) |
| Dec 2021 | - | $81.00 K(+50.0%) | $343.00 K(+6.5%) |
| Sept 2021 | - | $54.00 K(-53.0%) | $322.00 K(-15.5%) |
| June 2021 | $381.00 K(+39.6%) | - | - |
| June 2021 | - | $115.00 K(+23.7%) | $381.00 K(+30.9%) |
| Mar 2021 | - | $93.00 K(+55.0%) | $291.00 K(+20.2%) |
| Dec 2020 | - | $60.00 K(-46.9%) | $242.00 K(-16.0%) |
| Sept 2020 | - | $113.00 K(+352.0%) | $288.00 K(+5.5%) |
| June 2020 | $273.00 K(-38.5%) | $25.00 K(-43.2%) | $273.00 K(-19.5%) |
| Mar 2020 | - | $44.00 K(-58.5%) | $339.00 K(-19.9%) |
| Dec 2019 | - | $106.00 K(+8.2%) | $423.00 K(-1.2%) |
| Sept 2019 | - | $98.00 K(+7.7%) | $428.00 K(-3.6%) |
| June 2019 | $444.00 K(+31.8%) | $91.00 K(-28.9%) | $444.00 K(-3.3%) |
| Mar 2019 | - | $128.00 K(+15.3%) | $459.00 K(+11.4%) |
| Dec 2018 | - | $111.00 K(-2.6%) | $412.00 K(+3.8%) |
| Sept 2018 | - | $114.00 K(+7.5%) | $397.00 K(+17.8%) |
| June 2018 | $337.00 K(-38.6%) | $106.00 K(+30.9%) | $337.00 K(-30.8%) |
| Mar 2018 | - | $81.00 K(-15.6%) | $487.00 K(+5.9%) |
| Dec 2017 | - | $96.00 K(+77.8%) | $460.00 K(+0.9%) |
| Sept 2017 | - | $54.00 K(-78.9%) | $456.00 K(-16.9%) |
| June 2017 | $549.00 K(+14.6%) | $256.00 K(+374.1%) | $549.00 K(+7.2%) |
| Mar 2017 | - | $54.00 K(-41.3%) | $512.00 K(-25.0%) |
| Dec 2016 | - | $92.00 K(-37.4%) | $683.00 K(+9.8%) |
| Sept 2016 | - | $147.00 K(-32.9%) | $622.00 K(+29.9%) |
| June 2016 | $479.00 K(+260.2%) | $219.00 K(-2.7%) | $479.00 K(+59.1%) |
| Mar 2016 | - | $225.00 K(+625.8%) | $301.00 K(+157.3%) |
| Dec 2015 | - | $31.00 K(+675.0%) | $117.00 K(-8.0%) |
| Sept 2015 | - | $4000.00(-90.2%) | $127.20 K(-4.3%) |
| June 2015 | $133.00 K(+261.4%) | $41.00 K(0.0%) | $132.90 K(+24.0%) |
| Mar 2015 | - | $41.00 K(-0.5%) | $107.20 K(+49.5%) |
| Dec 2014 | - | $41.20 K(+324.7%) | $71.70 K(+71.1%) |
| Sept 2014 | - | $9700.00(-36.6%) | $41.90 K(+13.9%) |
| June 2014 | $36.80 K | $15.30 K(+178.2%) | $36.80 K(+72.8%) |
| Mar 2014 | - | $5500.00(-51.8%) | $21.30 K(+39.2%) |
| Dec 2013 | - | $11.40 K(+147.8%) | $15.30 K(+45.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2013 | - | $4600.00(-2400.0%) | $10.50 K(-17.3%) |
| June 2013 | $12.70 K(-86.7%) | -$200.00(-60.0%) | $12.70 K(-67.7%) |
| Mar 2013 | - | -$500.00(-107.6%) | $39.30 K(-51.6%) |
| Dec 2012 | - | $6600.00(-2.9%) | $81.20 K(-5.9%) |
| Sept 2012 | - | $6800.00(-74.2%) | $86.30 K(-9.4%) |
| June 2012 | $95.30 K(-39.4%) | $26.40 K(-36.2%) | $95.30 K(-21.0%) |
| Mar 2012 | - | $41.40 K(+253.8%) | $120.70 K(-20.4%) |
| Dec 2011 | - | $11.70 K(-25.9%) | $151.70 K(-11.3%) |
| Sept 2011 | - | $15.80 K(-69.5%) | $171.10 K(+8.8%) |
| June 2011 | $157.20 K(+369.3%) | $51.80 K(-28.5%) | $157.20 K(+34.2%) |
| Mar 2011 | - | $72.40 K(+132.8%) | $117.10 K(+141.9%) |
| Dec 2010 | - | $31.10 K(+1536.8%) | $48.40 K(+77.3%) |
| Sept 2010 | - | $1900.00(-83.8%) | $27.30 K(-18.3%) |
| June 2010 | $33.50 K(-65.0%) | $11.70 K(+216.2%) | $33.40 K(-37.0%) |
| Mar 2010 | - | $3700.00(-63.0%) | $53.00 K(-28.1%) |
| Dec 2009 | - | $10.00 K(+25.0%) | $73.70 K(-6.7%) |
| Sept 2009 | - | $8000.00(-74.4%) | $79.00 K(-17.4%) |
| June 2009 | $95.60 K(-97.2%) | $31.30 K(+28.3%) | $95.60 K(+11.9%) |
| Mar 2009 | - | $24.40 K(+59.5%) | $85.40 K(-49.1%) |
| Dec 2008 | - | $15.30 K(-37.8%) | $167.70 K(-80.8%) |
| Sept 2008 | - | $24.60 K(+16.6%) | $872.80 K(-74.2%) |
| June 2008 | $3.38 M(+36.7%) | $21.10 K(-80.2%) | $3.38 M(-32.6%) |
| Mar 2008 | - | $106.70 K(-85.2%) | $5.02 M(-3.7%) |
| Dec 2007 | - | $720.40 K(-71.6%) | $5.22 M(+5.7%) |
| Sept 2007 | - | $2.54 M(+52.6%) | $4.94 M(+99.3%) |
| June 2007 | $2.48 M(+195.6%) | $1.66 M(+455.3%) | $2.48 M(+168.4%) |
| Mar 2007 | - | $299.20 K(-31.8%) | $922.30 K(-2.0%) |
| Dec 2006 | - | $438.50 K(+472.5%) | $941.00 K(+55.4%) |
| Sept 2006 | - | $76.60 K(-29.1%) | $605.70 K(-27.7%) |
| June 2006 | $837.40 K(+1616.0%) | $108.00 K(-66.0%) | $837.40 K(+14.8%) |
| Mar 2006 | - | $317.90 K(+208.0%) | $729.40 K(+77.3%) |
| Dec 2005 | - | $103.20 K(-66.5%) | $411.50 K(+33.5%) |
| Sept 2005 | - | $308.30 K | $308.30 K |
| Sept 1999 | $48.80 K(-69.4%) | - | - |
| Sept 1998 | $159.60 K(+538.4%) | - | - |
| Sept 1997 | $25.00 K(-39.3%) | - | - |
| Sept 1996 | $41.20 K(-7.8%) | - | - |
| Sept 1995 | $44.70 K(+124.6%) | - | - |
| Sept 1994 | $19.90 K | - | - |
FAQ
- What is the all time high annual CAPEX for Perspective Therapeutics?
- What is the all time high quarterly CAPEX for Perspective Therapeutics?
- What is the all time high TTM CAPEX for Perspective Therapeutics?
What is the all time high annual CAPEX for Perspective Therapeutics?
Perspective Therapeutics all-time high annual capital expenditures is $3.38 M
What is the all time high quarterly CAPEX for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly capital expenditures is $2.54 M
What is the all time high TTM CAPEX for Perspective Therapeutics?
Perspective Therapeutics all-time high TTM capital expenditures is $5.22 M